Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease

Background. Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.Summary. L-ornithine L-aspartate (LOLA) has hepatoprotective properties in patients with fatty liver of diverse etiology and results of...

Full description

Bibliographic Details
Main Authors: Roger F. Butterworth, Ali Canbay
Format: Article
Language:Russian
Published: Gastro LLC 2019-03-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
l-ornithine l-aspartate
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
hepatoprotection
antioxidant
hepatic microcirculation
glutamine
Online Access:https://www.gastro-j.ru/jour/article/view/322

Internet

https://www.gastro-j.ru/jour/article/view/322

Similar Items